Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board
18 déc. 2018 07h30 HE
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development of...
Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Business Highlights
06 nov. 2018 06h56 HE
|
Cellular Biomedicine Group Inc.
Debuted its next 12-18 months’ immuno-oncology clinical development programs for both hematologic malignancies and solid tumors to key opinion leaders, investment and industry executivesLicensed...
Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pipeline Update and Facility Tour for Attendees of the Advanced Cell Therapy Summit in Shanghai
25 oct. 2018 08h56 HE
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors
03 oct. 2018 07h30 HE
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
CBMG（西比曼生物科技集团）针对中国患者与 CAR-T 细胞治疗领域的全球领导者达成战略许可和合作协议
27 sept. 2018 07h42 HE
|
Cellular Biomedicine Group Inc.
与诺华公司的合作内容包括以 4,000 万美元收购 CBMG 的1,458,257 股股票，对其开展股权投资，股票价格为每股 27.43 美元CBMG 将授权诺华公司在全球范围内使用其特定专有技术CBMG 将在中国生产和供应 Kymriah® (tisagenlecleucel） 上海和加利福尼亚州库比蒂诺, Sept. 27, 2018 (GLOBE NEWSWIRE) --...
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
24 sept. 2018 08h15 HE
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference
28 août 2018 09h16 HE
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group Reports Second Quarter and First Half 2018 Financial Results and Business Highlights
08 août 2018 07h31 HE
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- China Food and Drug Administration (CFDA) Accepts the Company’s Investigational New Drug (IND) Applications for anti-CD19...
Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland
22 juin 2018 09h00 HE
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., June 22, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia
21 juin 2018 07h30 HE
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...